BIND Therapeutics To Report First Quarter 2016 Financial Results On May 9, 2016
CAMBRIDGE, Mass.--(BUSINESS WIRE)--BIND Therapeutics, Inc. (NASDAQ: BIND), a biotechnology company developing targeted and programmable therapeutics called ACCURINS®, today announced it will host a conference call and audio webcast on May 9, 2016, at 8:30 a.m. ET to report first quarter 2016 financial results and provide a business update.